You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gastrin-releasing peptide receptor

Showing 1 - 25 of 9,449
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in Stockholm (68Ga-NOTA-PEG2-RM26)

Recruiting
  • Cancer
  • Stockholm, Sweden
    Karolinska University Hospital
Nov 23, 2023

Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • (no location specified)
Dec 1, 2022

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023

Prostate Cancer Trial in New York (68Ga-RM2 (RM2), PET/CT Scan)

Completed
Has Results
  • Prostate Cancer
  • 68Ga-RM2 (RM2)
  • PET/CT Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 27, 2021

Tumors Trial in Worldwide ([177Lu]-NeoB, [68Ga]-NeoB)

Recruiting
  • Neoplasms
  • Duarte, California
  • +9 more
Sep 12, 2022

Breast Cancer, Prostate Cancer, Colorectal Cancer Trial in Innsbruck, La Tronche, Pessac ([68Ga]-NeoBOMB1)

Terminated
Has Results
  • Breast Cancer
  • +4 more
  • Innsbruck, Austria
  • +2 more
Oct 22, 2020

Prostate Cancer, Breast Cancer Trial in Tomsk (Intravenous injection of [99mTc]Tc-DB8)

Recruiting
  • Prostate Cancer
  • Breast Cancer
  • Intravenous injection of [99mTc]Tc-DB8
  • Tomsk, Russian Federation
    TomskNRMC
Jul 4, 2023

Prostate Cancer, Breast Cancer Female Trial in Tomsk (whole body study and SPECT with 99mTc-RM26)

Enrolling by invitation
  • Prostate Cancer
  • Breast Cancer Female
  • whole body study and SPECT with 99mTc-RM26
  • Tomsk, Russian Federation
    TomskNRMC
Jul 4, 2022

Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

Recruiting
  • Breast Cancer
  • Sydney, New South Wales, Australia
    St Vincent's Hospital
May 22, 2023

Gastrointestinal Stromal Tumors Trial in Beijing (68Ga-NOTA-RM26)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Aug 6, 2021

Cervical Cancer, Prostate Cancer Metastatic, Breast Cancer Trial (²¹²Pb-DOTAM-GRPR1)

Recruiting
  • Cervical Cancer
  • +5 more
  • Chicago, Illinois
  • +3 more
Jan 24, 2023

Prostate Cancer Trial in Sydney (Copper-64 labelled SAR-Bombesin)

Recruiting
  • Prostate Cancer
  • Copper-64 labelled SAR-Bombesin
  • Sydney, New South Wales, Australia
    St Vincent's Hospital
Jan 8, 2023

Prostate Cancer Trial in Bordeaux (68Ga-PSMA-617 PET/CT, 68Ga-RM2 PET/CT)

Recruiting
  • Prostate Cancer
  • 68Ga-PSMA-617 PET/CT
  • 68Ga-RM2 PET/CT
  • Bordeaux, France
    Bordeaux University Hospital
Mar 29, 2022

Prostate Cancer Trial in Changsha (68Ga-PSMA PET/CT, 68Ga-GRP PET/CT)

Recruiting
  • Prostate Cancer
  • 68Ga-PSMA PET/CT
  • 68Ga-GRP PET/CT
  • Changsha, Hunan, China
    Department of PET Center,Xiangya Hospital,Central South Universi
Oct 10, 2021

Breast Carcinoma, Estrogen Receptor Positive Trial in Palo Alto (drug, procedure, device)

Suspended
  • Breast Carcinoma
  • Estrogen Receptor Positive
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Dec 8, 2021

Medullary Thyroid Carcinoma Trial in Worldwide (111In-CP04, 111In-CP04 with co-administration of gelofusine/gelaspan)

Completed
  • Medullary Thyroid Carcinoma
  • 111In-CP04
  • 111In-CP04 with co-administration of gelofusine/gelaspan
  • Innsbruck, Austria
  • +4 more
Mar 19, 2020

Thyroid Cancer, Medullary Trial in Basel (177Lu-PP-F11N, Sacuitril)

Completed
  • Thyroid Cancer, Medullary
  • Basel, Switzerland
    University Hospital Basel, Clinic for radiology and nuclear medi
Feb 9, 2022

Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2

Recruiting
  • Thyroid Cancer, Medullary
  • +3 more
  • Basel, Switzerland
    University Hospital Basel, Clinic for radiology and nuclear medi
May 23, 2022

Prostate Adenocarcinoma Trial in Palo Alto (Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, Magnetic Resonance Imaging,

Active, not recruiting
  • Prostate Adenocarcinoma
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
May 3, 2022

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

atoGepant In reaAl Life iN iTaly

Not yet recruiting
  • Migraine, Prophylaxis
  • (no location specified)
Nov 13, 2023

Gastric Bypass Trial in Fargo (Gastric bypass with transection of vagal nerves, Gastric bypass without transection of vagal

Recruiting
  • Gastric Bypass
  • Gastric bypass with transection of vagal nerves
  • Gastric bypass without transection of vagal nerves
  • Fargo, North Dakota
    Sanford Health
Nov 26, 2022